Metropolitan Life Insurance Company (MetLife)’s Invensense Inc INVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-56,743
| Closed | -$717K | – | 2627 |
|
|
2017
Q1 | $717K | Sell |
56,743
-512
| -0.9% | -$6.38K | 0.01% | 1413 |
|
|
2016
Q4 | $732K | Buy |
57,255
+8,183
| +17% | +$69.9K | 0.01% | 1486 |
|
|
2016
Q3 | $364K | Sell |
49,072
-3,714
| -7% | -$26.3K | ﹤0.01% | 1920 |
|
|
2016
Q2 | $324K | Hold |
52,786
| – | – | ﹤0.01% | 1975 |
|
|
2016
Q1 | $443K | Hold |
52,786
| – | – | ﹤0.01% | 1657 |
|
|
2015
Q4 | $540K | Buy |
52,786
+2,959
| +6% | +$32.8K | ﹤0.01% | 1577 |
|
|
2015
Q3 | $463K | Sell |
49,827
-2,925
| -6% | -$32.8K | ﹤0.01% | 1690 |
|
|
2015
Q2 | $797K | Sell |
52,752
-2,205
| -4% | -$33.3K | 0.01% | 1440 |
|
|
2015
Q1 | $836K | Hold |
54,957
| – | – | 0.01% | 1303 |
|
|
2014
Q4 | $894K | Hold |
54,957
| – | – | 0.01% | 1399 |
|
|
2014
Q3 | $1.08M | Hold |
54,957
| – | – | 0.01% | 1226 |
|
|
2014
Q2 | $1.25M | Buy |
54,957
+9,044
| +20% | +$185K | 0.01% | 1220 |
|
|
2014
Q1 | $1.09M | Hold |
45,913
| – | – | 0.01% | 1283 |
|
|
2013
Q4 | $954K | Hold |
45,913
| – | – | 0.01% | 1358 |
|
|
2013
Q3 | $809K | Hold |
45,913
| – | – | 0.01% | 1420 |
|
|
2013
Q2 | $706K | Buy |
+45,913
| New | +$543K | 0.01% | 1470 |
|
Metropolitan Life Insurance Company (MetLife)'s INVN Position: Q2 2017 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Invensense Inc (INVN) in Q2 2017, closing a stake of 56,743 shares — an estimated $717K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in INVN in Q2 2013 and held it in 16 quarters. The position peaked at $1.25M in Q2 2014. 0 funds tracked by Wall St. Rank hold INVN as of Q2 2017.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Invensense Inc position as of Q2 2017 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 56,743 Invensense Inc shares in Q2 2017, an estimated $717K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Invensense Inc in Q2 2013 and held it in 16 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Invensense Inc position peaked at $1.25M in Q2 2014.
- 0 funds tracked by Wall St. Rank held Invensense Inc as of Q2 2017.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2017, filed 14 Aug 2017.